Literature DB >> 20416958

Chondrogenic differentiation in femoral bone marrow-derived mesenchymal cells (MSC) from elderly patients suffering osteoarthritis or femoral fracture.

Felícito García-Álvarez1, Elena Alegre-Aguarón, Paula Desportes, María Royo-Cañas, Tomás Castiella, Luis Larrad, María José Martínez-Lorenzo.   

Abstract

This study analyzed the phenotype and the chondrogenic differentiation of bone marrow-derived MSCs from old patients undergoing knee osteoarthritis or femoral fracture surgery. Twenty patients (12 females), with a mean age of 77.35±8.76 years, were studied. Ten patients suffered of knee osteoarthritis (OA) pathology and underwent surgery for arthroplasty, and the other 10 patients suffered femoral fracture. A comparative study of bone marrow-derived cultured human MSCs was carried out, and the main morphological parameters, proliferative activity and expression of surface markers were characterized. Bone marrow was obtained from the femur in all cases. The χ2-test, Mann-Whitney U-test, correlation coefficient and the Spearman test were applied. Bone marrow MSCs from old patients were able to differentiate into chondrocytic lineages. Proliferation and flow cytometry data showed no difference associated to the gender. No significant differences between the knee arthroplasty group or the femoral fracture group were found, except for higher CD49d % in MSC from fracture, and higher CD49f % in MSC from knee OA patients at passage one. MSCs from old patients suffering knee OA can be differentiated into chondrocytic lineages, and these present no differences with MSCs from femoral fracture patients.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20416958     DOI: 10.1016/j.archger.2010.03.026

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  12 in total

1.  Infrapatellar fat pad-derived stem cells maintain their chondrogenic capacity in disease and can be used to engineer cartilaginous grafts of clinically relevant dimensions.

Authors:  Yurong Liu; Conor Timothy Buckley; Henrique V Almeida; Kevin J Mulhall; Daniel John Kelly
Journal:  Tissue Eng Part A       Date:  2014-07-08       Impact factor: 3.845

Review 2.  Stem cell-based therapies for osteoarthritis: challenges and opportunities.

Authors:  Brian O Diekman; Farshid Guilak
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

3.  Modulation of Hyaluronan Synthesis by the Interaction between Mesenchymal Stem Cells and Osteoarthritic Chondrocytes.

Authors:  Eliane Antonioli; Carla A Piccinato; Helena B Nader; Moisés Cohen; Anna Carla Goldberg; Mario Ferretti
Journal:  Stem Cells Int       Date:  2015-07-26       Impact factor: 5.443

4.  Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy.

Authors:  Wen Yu; De-Dong Cao; Qiu-Bai Li; Hui-Ling Mei; Yu Hu; Tao Guo
Journal:  Oncotarget       Date:  2016-12-27

Review 5.  The use of mesenchymal stem cells for cartilage repair and regeneration: a systematic review.

Authors:  Andy Goldberg; Katrina Mitchell; Julian Soans; Louise Kim; Razi Zaidi
Journal:  J Orthop Surg Res       Date:  2017-03-09       Impact factor: 2.359

6.  Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro.

Authors:  Juliana Redondo; Pamela Sarkar; Kevin Kemp; Paul F Virgo; Joya Pawade; Aimie Norton; David C Emery; Martin G Guttridge; David I Marks; Alastair Wilkins; Neil J Scolding; Claire M Rice
Journal:  Mult Scler       Date:  2017-05-26       Impact factor: 6.312

7.  Dysregulation of Mesenchymal Stromal Cell Antioxidant Responses in Progressive Multiple Sclerosis.

Authors:  Juliana Redondo; Pamela Sarkar; Kevin Kemp; Kate J Heesom; Alastair Wilkins; Neil J Scolding; Claire M Rice
Journal:  Stem Cells Transl Med       Date:  2018-07-31       Impact factor: 6.940

8.  Pelleted Bone Marrow Derived Mesenchymal Stem Cells Are Better Protected from the Deleterious Effects of Arthroscopic Heat Shock.

Authors:  Gauthaman Kalamegam; Mohammed Abbas; Mamdooh Gari; Haneen Alsehli; Roaa Kadam; Mohammed Alkaff; Adeel Chaudhary; Mohammed Al-Qahtani; Adel Abuzenadah; Wael Kafienah; Ali Mobasheri
Journal:  Front Physiol       Date:  2016-05-24       Impact factor: 4.566

9.  Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis.

Authors:  Pamela Sarkar; Juliana Redondo; Kevin Kemp; Mark Ginty; Alastair Wilkins; Neil J Scolding; Claire M Rice
Journal:  Cytotherapy       Date:  2017-09-13       Impact factor: 5.414

Review 10.  Emerging Gene-Editing Modalities for Osteoarthritis.

Authors:  Alekya S Tanikella; Makenna J Hardy; Stephanie M Frahs; Aidan G Cormier; Kalin D Gibbons; Clare K Fitzpatrick; Julia Thom Oxford
Journal:  Int J Mol Sci       Date:  2020-08-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.